Our technology empowers our clients and partners to rapidly advance new peptide-based leads with high affinity and specificity.
With our platform we improve the odds of discovering high quality leads with drug-like properties that deliver outcomes best suited to our clients needs.
Our peptide discovery technology is at the forefront of innovation, designed to empower your journey in finding novel therapies.
We combine chemically modified phage display, cutting-edge bioinformatics, and diverse libraries architectures to revolutionize peptide discovery for a wide spectrum of applications.
Access to a vast and diverse range of phage libraries for enhanced lead identification: including small, medium, and large ring sizes.
Introduce modifications to quickly produce high value assets: including mono-and-bi cyclic modifications, attachment of linkers and payloads (ideal for radiopharmaceutical and siRNA delivery).
Discovery campaigns for a wide range of targets, including integrated cell panning campaigns.
Advanced bioinformatics tools to streamline data analysis and accelerate decision-making.
Faster lead identification and optimization, reducing time to market.
Tailor solutions precisely to project needs, improving overall success rates and outcomes.
Leverage our comprehensive data analysis for informed decision-making and strategy.
Optimize resources and investments while maximizing results with our cost-effective technology.
Stay ahead in the industry by utilizing our cutting-edge technology for peptide discovery.
Our clients and partners include emerging startups to leading global pharmaceutical entities around the world.
Discover how our technology can accelerate your peptide discovery. Reach out to us today to partner for innovative and effective peptide development solutions!